Skip to content
  •   Site Login
  •   Site Login
HiFlow - COPD Study - myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD patients in the home – a multi-center randomized controlled trial
  • Home
  • About HiFlo
    • Who Is Eligible
  • Study Locations
  • About COPD
  • About Clinical Trials
Menu
  • Home
  • About HiFlo
    • Who Is Eligible
  • Study Locations
  • About COPD
  • About Clinical Trials
Am I Eligible?

Login

Register
Forgot your password?

View this Study on ClinicalTrials.Gov

NCT05204888 - myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD Patients in the Home

Participate in the HiFlo COPD Study

Learn more about your condition, gain access to new therapies, and contribute to medical advances.

Am I Eligible?
HiFlow - COPD Study - myAirvo 3 (High Flow Nasal Therapy; HFNT) for COPD patients in the home – a multi-center randomized controlled trial

HiFlo COPD Coordinating Site:

Temple University Hospital
3401 N. Broad Street
Philadelphia, PA 19140

Copyright © 2023 Temple University Hospital

TERMS OF USE

PRIVACY & NON-DISCRIMINATION NOTICES

WEB PRIVACY POLICY

Website by ImageBloom website design and marketing for clinical research industry